Apheresis in Neurological Disorders TreatmentAuthor(s): Erica Bronen
In a variety of medical sectors, Plasma Exchange (PE) and Immunoadsorption (IA) are important therapy alternatives for autoimmune illnesses. Their pathophysiological explanation is primarily focused on the removal of autoantibodies and the maintenance of a healthy immune system. Apheresis is a promising therapy strategy from a theoretical aspect since it works by eliminating pathogenic components rather than administering drugs that can have major side effects. The neurological indications include Multiple Sclerosis (MS) steroid-refractory recurrence, myasthenia gravis, Autoimmune Encephalitis (AE), Guillain-Barre Syndrome (GBS), and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).